Health & Environmental Research Online (HERO)


Print Feedback Export to File
2816863 
Journal Article 
Concentrations of phthalate metabolites in breast milk in Korea: estimating exposure to phthalates and potential risks among breast-fed infants 
Kim, S; Lee, J; Park, J; Kim, HJ; Cho, G; Kim, GH; Eun, SH; Lee, JJ; Choi, G; Suh, E; Choi, S; Kim, S; Kim, YD; Kim, SK; Kim, SY; Kim, S; Eom, S; Moon, HB; Kim, S; Choi, K 
2015 
Science of the Total Environment
ISSN: 0048-9697
EISSN: 1879-1026 
ELSEVIER 
AMSTERDAM 
Sci Total Environ. 2015, Mar 01; 508:13-9. [The Science of the total environment] 
508 
13-19 
English 
Phthalates have been associated with endocrine disruption and developmental effects in many experimental and epidemiological studies. Developing infants are among the most susceptible populations to endocrine disruption. However, limited information is available on phthalate exposure and its associated risks among breast-fed newborn infants. In the present study, breast milk samples were collected from 62 lactating mothers at 1 month post-partum from four cities of Korea in 2012 and were evaluated for six phthalate metabolites (mono-isobutyl phthalate (MiBP), mono-n-butyl phthalate (MnBP), mono(2-ethyl-hexyl) phthalate (MEHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and monoethyl phthalate (MEP)). MEP was detected in all breast milk samples, with a median concentration of 0.37 μg/L, and MiBP, MnBP and MEHP were detected in 79-89% of samples, with median concentrations of 1.10, 1.70, and 2.08 μg/L, respectively. However, MEHHP and MEOHP, the oxidized forms of di-ethyl-hexyl phthalate (DEHP), were detected in only one sample. For exposure assessment, the levels of phthalate diesters were estimated based on the parent:metabolite ratios in the breast milk that are reported elsewhere. For risk assessment, the endocrine-related toxicity of the monoester was assumed to be the same as that of its diester form. Median daily intake estimates of phthalates, including both monoester and diester forms, through breast milk consumption ranged between 0.91 and 6.52 μg/kg body weight (bw) for DEHP and between 0.38 and 1.43 μg/kg bw for di-n-butyl phthalate (DnBP). Based on the estimated daily intake, up to 8% of infants exceeded the reference dose of anti-androgenicity (RfD AA) for DEHP, and 6% of infants exceeded the tolerable daily intake (TDI) for DnBP. Breast milk MiBP and MnBP concentrations showed significant positive associations with maternal consumption of whipped cream or purified water. Considering vulnerability of young infants, efforts to mitigate phthalate exposure among lactating women are warranted. 
DEHP; MEHP; DnBP; Daily intake; CHECK 
IRIS
• Dibutyl Phthalate (DBP)
     Database Searches
          Litsearch September 2014 - February 2015
               Pubmed
          Litsearch March 2015 - June 2015
               Pubmed
               WOS
          LitSearch Jul 2016 - Jan 2017
               Prior search overlap
               WoS
     Excluded: No Primary Data on Health Effects
          Exposure levels
     Secondary Literature
          Risk assessments
     Litsearch June 2015 - Jan 2016
          Web of Science
• Diethyl phthalate (DEP)
     Database searches
          Jan 2020 update
               PubMed
               Web of Science
               New for this project
     Excluded: No Primary Data on Health Effects
          Exposure levels
• Diisobutyl Phthalate (DIBP) Final
     Database Searches
          June 2015 Update
               Toxline
               Web of Science
               New for this Search
          December 2015 Update
               Web of Science
          June 2016 Update
               Toxline
               Web of Science
          January 2017 Update
     No Primary Data on Toxic Effects
          Exposure levels
• Phthalates – Targeted Search for Epidemiological Studies
     Source – all searches
          Pubmed
     Excluded
     Source – Mar 2015 Update (Private)
          Pubmed
     Source – Dec 2015 Update (Private)
          Pubmed